Browse our complete database | AME

All filters

Slidesets

Integrating PrEP in prevention | Robert Grant, MD, MPH

Presented at:

APACC 2016

Slidesets

Transmission networks among MSM | Shui-Shan Lee, MD, FRCP, FRCPA, FFPH

Presented at:

APACC 2016

Slidesets

Long-term comorbidities | Saye Khoo, MD, PhD

Presented at:

APACC 2016

Slidesets

Hyperlipidaemia and its association with CD4 recovery following antiretroviral therapy | Denise Chan

Presented at:

APACC 2016

Slidesets

Clinical case presentation | Man-Po Lee, MBBS, MSc, FHKCP, FHKAM, FRCP

Presented at:

APACC 2016

Slidesets

Aspartate Aminotransferase to Platelet Ratio Index (APRI) is a Simple Test for Diagnosis Liver Cirrhosis in HIV Patients | Dr. K. Mariad

Presented at:

APACC 2016

Slidesets

Metabolic Syndrome among Malaysian HIV-Infected Patients: Preliminary Results from the HIV & Ageing Cohort | Sivaraj Naidu, MMedSc

Presented at:

APACC 2016

Slidesets

Sofosbuvir and Ribavirin therapy for the Treatment of HIV/HCV co-infected patients with HCV GT1-4 Infection: The PHOTON-1 and -2 Trials|||| Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1 | Dr. J. Rockstroh

Presented at:

APACC 2016

Slidesets

Development of HIV Vaccine Candidates for Prevention and Treatment | Sandhya Vasan, MD

Presented at:

APACC 2016

Slidesets

Clinical case presentation | Mark Nelson, MD

Presented at:

APACC 2016

Slidesets

(Abstract) The effect of antiretroviral naïve HIV-1 infection on the ability of autologous NK cells to produce IFNg unpon exposure to Plasmodium falciparum- infected Erythrocytes | C. Sake Ngane

Presented at:

INTEREST 2016

Slidesets

(Abstract) Evaluating plasmatic biomarkers as disease signatures for the point of care monitoring of HIV-1 and comorbidities in resource limited regions | G. Nchinda

Presented at:

INTEREST 2016

Slidesets

(Abstract) Immune reconstitution and skewed responses after ART initiation in HIV I infected Ugandans | K. Nganou Makamdop

Presented at:

INTEREST 2016

Slidesets

(Abstract) HIV-1 group O infection in Cameroon from 2006 to 2013: prevalence, genetic diversity, evolution and public health challenges | A.F. Aghokeng

Presented at:

INTEREST 2016

Slidesets

(Abstract) Outcomes of second-line therapy in HIV positive adults attending for routine care at Yaoundé Central Hospital | A.O. Mafotsing Fopoussi

Presented at:

INTEREST 2016

Slidesets

Progress in Hepatitis B and C in sub-Saharan Africa | Magloire Biwole Sida, MD

Presented at:

INTEREST 2016

Slidesets

M-Health for HIV | Cees Hesp

Presented at:

INTEREST 2016

Slidesets

HIV Leadership and Financing Strategies for Countries in sub-Saharan Africa | Debrework Zewdie, PhD

Presented at:

INTEREST 2016

Slidesets

Where Do We Stand in 2016 | Andrew Hill, PhD

Presented at:

INTEREST 2016

Slidesets

Evolving Treatment Paradigms: Relevance in Resource- Limited Settings | Nicholas Paton, MD, FRCP

Presented at:

INTEREST 2016

Slidesets

Acquired Drug Resistance: Causes, Patterns, and Implications for SSA | Coumba Toure Kane, PharmD, PhD

Presented at:

INTEREST 2016

Slidesets

Progress on viral load monitoring, laboratory quality assurance, point of care | John Nkengasong, PhD

Presented at:

INTEREST 2016

Slidesets

Lessons learnt from Ebola Therapeutic Trials and Survivor Cohort Studies | Daouda Sissoko, MD

Presented at:

INTEREST 2016

Slidesets

Lessons learnt About Good Participatory Practices in Prevention and Treatment Trials for HIV and for Emerging Pathogens | Lillian Mutengu

Presented at:

INTEREST 2016